You Missed the First Decade of Winners.
The Next One Drops Monday, July 27 at 3:00pm ET.

Join Cabot Stock of the Week during this 10^th anniversary celebration...

Lock in your 60% discount and receive Chris Preston’s next recommendation.

Right now, locked inside Cabot's research network, there is the name of a single stock.

One company, chosen from across our vast network of advisories.

And on Monday, July 27 at 3:00pm ET, a small group of investors will receive that name.

So I asked our Chief Analyst for something special…

Not Just the Next Pick —
The Next Long-Term Winner

Most weeks, Chris Preston chooses the best stock to own right now.

But this recommendation marks ten years of Cabot Stock of the Week and the beginning of the next ten.

So I asked him to do something different…

I asked him to search the entire Cabot network for a company that could become far more than a good trade…

A business with the growth and the long-term potential that we could still be talking about on Cabot Stock of the Week's 20^th anniversary.

The first decade built the record.

So I wanted the next pick to help define the second.

And Chris just found it!

He compared the strongest candidates from across seven Cabot advisories…

Challenged every investment case...

Until one was left standing.

One company that fit everything I asked him to find.

Because it's chasing what may be the most important medical breakthrough of our lifetime: catching cancer with a single vial of blood.

Last year alone, more than 2 million Americans were diagnosed with cancer. More than 618,000 will die from it, roughly 1,700 people every single day.

For decades, the deadliest part of that fight has been the same: by the time cancer is found, it's often too late.

This company is attacking that exact problem.

Its technology can screen for cancer, monitor it, and profile it from a simple blood draw, no invasive procedure required.

And it's so effective that the biggest player in the industry is adopting it…

The largest commercial health insurer in America has agreed to cover the company's cancer test…

And that coverage goes live in a matter of days: on August 1st.

Overnight, this test becomes accessible to more than 100 million Americans.

It's the first and only FDA-approved blood test of its kind…

Already written into the guidelines of both the American Cancer Society and the National Comprehensive Cancer Network.

And Wall Street has started to notice...

Over the last twelve months,
the stock has climbed 236%.

But here's why Chris chose it to open the next decade…

This isn't a company chasing a fad that fades in a year.

It's building the infrastructure for how cancer gets caught — earlier, faster, and for millions more people — for the next ten years and beyond.

And Chris is revealing the name and ticker symbol of this company:
Monday, July 27 at 3:00pm ET.

This one you can get from the very beginning.

If Cabot Stock of the Week’s first decade taught us anything, it's that getting in early is game-changing.

Ten years ago, tock of the Week’ sent out its very first Monday recommendation.

Since then, investors have lived through a pandemic… interest rates at zero, then climbing at the fastest pace in decades… the return of inflation… and the rise of AI as the most powerful force in the market.

Through every one of those moments, another Monday always arrived.

And with it, another stock to consider.

Some of those Mondays turned into the kind of gains investors remember for years…

Like a 200% gain on half a position in AST SpaceMobile in less than one year…

A 181% gain on half a position in Broadcom in 16 months…

Those returns belong to the first decade now. They're history.

But the companies that will define the next decade are still out there.

And one of them, the one Chris already chose, could be the next one.

It Only Takes One Great Stock
to Change the Game

Every so often, Cabot finds one home run early and holds on.

On December 29, 2011, a Cabot analyst recommended a then-controversial electric-car company most investors thought was a joke.

That company was Tesla.

It went on to become a Heritage Stock in the Cabot Stock of the Week portfolio, a rare designation we reserve for a winner with enough long-term potential to keep its place for years.

As of June 2026, Tesla had risen more than 22,000% since that original recommendation.

Now… No publisher would promise the next pick becomes the next Tesla.

And, not all picks are big winners. Some aren’t even winners at all. But Stock of the Week has had many big winners, like Tesla and the other examples I’ll mention in this letter.

I’ve chosen them to show you what we have picked in the past and what is possible but they are not representative or average.

And of course, investing always involves the risk of loss.

We can’t guarantee returns but we can guarantee we will keep looking for the next Tesla, Amazon, Apple or Microsoft.

That is exactly the kind of company Chris went looking for.

Not a quick trade. A business built to grow for the next 10 years.

The kind of stock we could still be talking about when Cabot Stock of the Week turns twenty.

And he’s already found it.

But before I show you how you can get access…

Let me show you why Cabot Stock of the Week can find winners almost no one else can.

The reason comes down to a single word…

Freedom.

It's the one thing almost no analyst on Wall Street actually has…

And it's the reason our single weekly recommendation can do what most professionals can't.

Because make no mistake: beating the market is hard.

Over the past 10 years, 86% of actively managed U.S. large-cap funds failed to beat the S&P 500, according to SPIVA.

Nearly nine out of ten professional money managers — people who do this full-time, with research budgets, Bloomberg terminals, and teams of analysts — couldn't outperform a simple index fund.

But, right now, the Cabot Stock of the Week portfolio is sitting on a 46% average return across all open positions.

So what makes the difference?

Most of those managers are locked inside a single investment style…

A growth analyst hunts growth stocks: even in a year when growth is getting crushed.

A value analyst hunts bargains.

An income analyst can only look at dividend payers.

They're specialists…

But the market doesn't care what an analyst happens to specialize in.

One year the money pours into technology…

The next it rotates into banks… then healthcare… then gold… then small caps… then the boring, overlooked businesses everyone had written off.

The opportunity is always moving.

And an analyst locked in one corner can only watch it move away.

Cabot Stock of the Week was built to solve exactly that problem.

Instead of one analyst trapped in one style, it draws on seven.

Each scanning a different part of the market at the same time:

• Growth stocks from Cabot Growth Investor
• Momentum stocks from Cabot Momentum Trader
• Stocks showing unusual insider activity from Cabot Insider Edge
• Undervalued companies from Cabot Value Investor
• Income opportunities from Cabot Dividend Investor
• Emerging small-cap stocks from Cabot Early Opportunities
• And international opportunities from Cabot Explorer

That's why, when one part of the market goes cold, Chris doesn't have to force picks from a slow sector.

He just looks where the money is actually moving.

Take this year as an example…

While most investors chased the same handful of AI names, two of the strongest performers in the portfolio were …

a "boring" bank stock that’s up 83% in the last 15 months, and…

a "boring" delivery company that’s up 47% in the last seven months.

But that's what happens when you're free to look everywhere instead of being locked into just one sector or strategy.

As Chris puts it:

"There's always a bull market somewhere."

The hard part is finding where before everyone else does.

Seven research teams give him more places to look. But seven only narrows the field.

Someone still has to make the final call to take the strongest idea and choose the one stock that goes out each Monday morning.

That’s why I did not entrust that responsibility to just anyone…

Cabot Stock of the Week is one of the most important advisories we publish.

So when it came time to choose the person who would lead it in 2022, I chose Chris Preston.

Chris joined Cabot in 2015 and has spent more than a decade analyzing investments.

That judgment matters because Chris’s job is not merely to collect recommendations from Cabot’s analysts.

It is to compare the strongest opportunities coming from across our research network and ask:

“Of all the stocks Cabot’s specialists are recommending right now, which one offers our subscribers the most compelling opportunity in today’s market?”

Then Chris uses his experience to handpick the one idea he believes deserves your attention most.

Now, that does not mean every recommendation will become a major win.

No one can guarantee that.

It means Monday’s stock is not being chosen simply because it fits one analyst’s strategy.

But talking is easy…

Let me show you what this weekly process has actually produced.

While the Market Crashed and Soared,
Another Monday Winner Was Always Waiting

Across a decade, through a pandemic, bear markets, and the strongest bull run in a generation, we survived and thrived.

In early 2020, businesses closed, markets collapsed, and no one knew what the world would look like in a month because of Covid.

But weeks before the worst of it, Cabot Stock of the Week had already recommended Sea Limited, a fast-growing Southeast Asian company in e-commerce and digital payments.

By June, the position showed an open gain of 175%.

Then, on March 17 — as lockdowns spread — came the Zoom Video Communications recommendation, just as millions were forced to work and learn from home.

By June 21, Zoom was up 132%.

This wasn't luck.

Even as the market panicked, the Cabot network was finding the handful of companies whose businesses were growing in the chaos.

When the Market Fell Apart in 2022 —
Another Monday Arrived

Two years later, the S&P 500 dropped nearly 20%.

Most investors were focused on avoiding more losses, not finding winners.

But by late December 2022, the Cabot Stock of the Week portfolio was holding open gains of 40% in Enphase Energy, 25% in Xponential Fitness, and 21% in Ulta Beauty.

While the indexes bled, the network kept finding individual stocks that worked.

Then Chris Preston Took the Helm
and the Wins Kept Coming

Chris became Chief Analyst in 2022, inheriting a proven system. And he went to work running it…

Novo Nordisk entered the Cabot Stock of the Week portfolio on December 27, 2022.

The market had just endured one of its most difficult years.

But Chris saw that the Danish pharmaceutical company had become a global leader in diabetes care…

And its obesity treatments were beginning to open what could become one of the largest new markets in the healthcare industry.

The recommendation went on to produce a 68% gain before the position was closed on October 28, 2024.

In March 2023, Chris recommended Eli Lilly, just as the pharmaceutical giant was emerging as a leader in the obesity and diabetes breakthrough.

By the time the position closed in August 2025, it had produced a 95% gain, nearly doubling in less than two and a half years!

In September 2023, Chris also recommended CrowdStrike, a leader in cloud cybersecurity, essential infrastructure for governments and businesses worldwide.

When the position closed in July 2024, it had delivered a 62% gain.

One system finding winners through all of it.

And it's still working right now.

As of July 20, 2026, the portfolio held open gains including:

• 83% in a semiconductor company powering the AI boom…
• 111% in a prominent international bank…
• And 78% in a leading global innovator of materials science.

Three different paths to profit…

And all still open and reserved for Cabot Stock of the Week subscribers.

Which brings us back to the one question that matters now, our Monday recommendation.

Chris already made his choice…

• The company on the front line of catching cancer with a simple blood test.
• The one whose test reaches 100 million Americans on August 1st.
• The one already up 236% in the last 12 months that could be about to go even higher.

But identifying a promising stock
is only the first step…

That is why Cabot Stock of the Week does not simply send you a ticker symbol on Monday and disappear.

Once a stock enters the portfolio, Chris continues monitoring the company…

• Then he tells subscribers when the stock remains a Buy…
• When it is better rated Hold…
• When it may be prudent to Take Partial Profits while allowing the remaining shares to continue profiting…
• And when the opportunity has changed enough that it is time to Sell and move on.

Every Monday, that rating gets reviewed against what actually happened in the market that week.

So you're never sitting on a stock wondering, "Do I hold through this drop or is this the one I should've sold?"

You'll always know.

That's the difference between investing and hoping.

Here's What You Get the Moment You Join:

• A new recommendation every Monday: one stock, chosen from across all seven Cabot advisories, delivered with the full original research from the analyst who knows it best.
• A plain-English market briefing: before every recommendation, a quick read on what's driving the market and whether conditions call for confidence or caution.
• A focused portfolio: no more than 25 stocks. Never an unmanageable pile of forgotten positions. Tight enough to actually follow, diverse enough to spread your opportunities.
• Special alerts the moment something can't wait: if a stock breaks down or news hits between Mondays, you hear about it right away. You're never blindsided.
• Direct access to Chris: have a question about a recommendation, a rating? You can email Chris directly. He can't give personalized investment advice, but you're not shouting into a void: there's a real person on the other end.

Plus a Free Gift:
How to Be a Successful Investor for Life

When you join, Chris wants you to have something he's spent a lifetime putting together.

It's a special report with the hard lessons in investing, distilled into ten plain rules.

These are the same rules that have kept Cabot Stock of the Week's winners growing and its losses small for years.

Inside, you'll discover:

• The single most dangerous moment to "buy the dip"…
• Why the news is the worst guide to a stock's future and the one thing to trust instead…
• When to take profits without killing your upside: the exact point Chris trims a winner and lets the rest run…
• The four warning signs it's time to sell a stock: most investors miss every one of them until it's too late…
• And much more…

Yours free the moment you join and yours to keep, no matter what you decide.

That’s the knowledge, the research, the watching, the hard "hold-or-fold" calls… All done for you.

And for a lot of subscribers, that's the real value.

Not just the gains…

The relief of knowing exactly what to do with every stock they own, every week, without second-guessing.

Here's what Cabot Stock of the Week
subscribers say in their own words…

⭐⭐⭐⭐⭐

“I have subscribed to Cabot Stock of the Week since its inception in 2016. I have chosen this Cabot investment letter because it works best with my limited resources and my very limited knowledge of stock trading. So far, to date, my portfolio is up 75%. Yes, there have been a couple of losses which I limited to 10% and 12%. But overall I have no complaints, none whatsoever.” -P. Hyra, Burton, New Brunswick, Canada

⭐⭐⭐⭐⭐

“An easy way to invest without any worry.” - Aston, Florence, Alabama

⭐⭐⭐⭐⭐

“Thank you for finding Tesla stock when it was relatively unknown—that’s what allowed me to buy my Model X.” - Rod Kieft, Anchorage, Alaska

⭐⭐⭐⭐⭐

“Man, that IQ pick was straight up brilliant!” - Jodie H. Ruston, Louisiana

⭐⭐⭐⭐⭐

“It is your qualities of truthfulness, honesty and candor that have drawn me to the Cabot family of letters and to date, I am very pleased. The yo-yo effect of the market has not phased me. Reading your letters are like a prayer to me...they calm me.”- A. Khorsandian, Daytona Beach, Florida

⭐⭐⭐⭐⭐

“This is exactly the kind of information I need. Please keep it up.” - T. Picking, Pueblo, Colorado

⭐⭐⭐⭐⭐

“I am ‘blown away’ by the value I receive from the Cabot group. You offer even more than promised. Kindest regards”- Sophia Z., Long Island City, New York

You Could Do This Yourself.
But Here's What It Would Cost You…

Everything Chris does each week, you could attempt on your own.

You'd just need to subscribe to all seven Cabot advisories, read every recommendation they publish, compare them head to head, and decide which single stock deserves your money this week.

Here's what those seven memberships cost:

Cabot Growth Investor — $697 a year

Cabot Momentum Trader — $697 a year

Cabot Insider Edge — $697 a year

Cabot Value Investor — $397 a year

Cabot Dividend Investor — $597 a year

Cabot Early Opportunities — $997 a year

Cabot Explorer — $1,997 a year

Total: $6,079 a year.

But Cabot Stock of the Week does all of that for you…

For a small fraction of what those seven memberships cost.

And Because This Is Our 10th Anniversary —

We have a special introductory offer for you.
Try it for 6 Months at 60% Off

We're not marking ten years by asking you to commit to full price, or to a full year.

Instead, to celebrate the start of the next decade, we're inviting you to try Cabot Stock of the Week for six months at 60% off the regular rate.

Why six months?

Because one recommendation doesn't prove anything.

We want you to judge the service the way it's meant to be judged…

Over 25 weekly issues, with new recommendations, ongoing Buy / Hold / Sell guidance, portfolio updates and special alerts.

100% Money-Back Guarantee:
You Risk Nothing for 30 Days

Join today and you will get the next recommendation, the full portfolio and your free report.

Read them. Follow Monday's pick. See how Chris manages the portfolio in real market conditions.

If, anytime in your first 30 days, you decide it's not for you…

Tell us, and we'll refund every penny. 100%.

So you're not committing to anything today.

You're simply giving Cabot Stock of the Week 30 days to prove what a decade has already shown.

But Make Sure You’re Inside Before Monday’s, July 27^th Recommendation Arrives

Once the new issue is published, Cabot Stock of the Week subscribers will receive the complete recommendation…

Including the company’s name and ticker symbol…

The full investment case from the Cabot analyst who originally identified the opportunity…

And Chris's own reasoning for why he believes this company could grow over the next decade.

To make sure you receive that recommendation when it is released, you need to join Cabot Stock of the Week by Monday.

That is also when this special 10^th anniversary offer is scheduled to end.

After the deadline, the 60% anniversary discount will no longer be available.

The first 10 years of Cabot Stock of the Week are already history.

But the next recommendation has not been published yet.

You can still be there when it arrives.

What Could the Next Monday
Mean for You?

Consider the best-case scenario.

You join Cabot Stock of the Week during this 10^th anniversary celebration.

You lock your 60% discount and receive Chris Preston’s next recommendation Monday.

Then another carefully selected opportunity the following week…

And another after that.

Some picks may produce gains soon. Some may require patience. Others may disappoint and need to be sold.

But somewhere among the recommendations published, you may discover one or more stocks that become important to your financial future…

Enough over time to make you very wealthy.

That possibility makes being present next Monday so valuable.

And what is the worst-case scenario for your subscription?

You join today…

And if, during your first 30 days, you decide Cabot Stock of the Week is not right for you, you request a full refund.

You can examine it personally for 30 days and make that decision based on your own experience … and full access to the entire advisory service benefits.

So the choice before you is straightforward.

You can remain out…

Watch the next Monday recommendation arrive without you…

And perhaps, years from now, read about the stocks that became the success stories of Cabot Stock of the Week’s second decade.

Or you can start now…

You can receive the next recommendation from the start…

Follow the research as the story unfolds…

And give Cabot Stock of the Week six months to prove what its weekly process could do for you.

Your next step is simply to review the special 10^th anniversary terms on the following page.

Click below to receive your six-month membership at 60% off…

And make sure you are inside before Chris releases his next recommendation this Monday, July 27 at 3:00pm ET.